These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38043691)

  • 21. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles.
    Colino CI; Lanao JM; Gutierrez-Millan C
    Front Immunol; 2020; 11():218. PubMed ID: 32194546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage membrane-coated nanovesicles for dual-targeted drug delivery to inhibit tumor and induce macrophage polarization.
    Huang X; Wang L; Guo H; Zhang W
    Bioact Mater; 2023 May; 23():69-79. PubMed ID: 36406251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways.
    Zhou D; Huang C; Lin Z; Zhan S; Kong L; Fang C; Li J
    Cell Signal; 2014 Feb; 26(2):192-7. PubMed ID: 24219909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage-Targeted Lung Delivery of Dexamethasone Improves Pulmonary Fibrosis Therapy via Regulating the Immune Microenvironment.
    Sang X; Wang Y; Xue Z; Qi D; Fan G; Tian F; Zhu Y; Yang J
    Front Immunol; 2021; 12():613907. PubMed ID: 33679754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic reprogramming of macrophages and its involvement in inflammatory diseases.
    Guo C; Islam R; Zhang S; Fang J
    EXCLI J; 2021; 20():628-641. PubMed ID: 33883988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of prostaglandin E2 in macrophage polarization: Insights into atherosclerosis.
    Wang W; Liang M; Wang L; Bei W; Rong X; Xu J; Guo J
    Biochem Pharmacol; 2023 Jan; 207():115357. PubMed ID: 36455672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis.
    Wen JH; Li DY; Liang S; Yang C; Tang JX; Liu HF
    Front Immunol; 2022; 13():946832. PubMed ID: 36275654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer.
    Mukhtar M; Ali H; Ahmed N; Munir R; Talib S; Khan AS; Ambrus R
    Expert Opin Drug Deliv; 2020 Sep; 17(9):1239-1257. PubMed ID: 32543950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural products targeting macrophages in tumor microenvironment are a source of potential antitumor agents.
    Liu QP; Chen YY; An P; Rahman K; Luan X; Zhang H
    Phytomedicine; 2023 Jan; 109():154612. PubMed ID: 36610172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.
    Estko M; Baumgartner S; Urech K; Kunz M; Regueiro U; Heusser P; Weissenstein U
    BMC Complement Altern Med; 2015 Apr; 15():130. PubMed ID: 25902944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological macromolecules based targeted nanodrug delivery systems for the treatment of intracellular infections.
    Aparna V; Shiva M; Biswas R; Jayakumar R
    Int J Biol Macromol; 2018 Apr; 110():2-6. PubMed ID: 29355638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer.
    Wei Y; Zhu M; Schober A
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting different phenotypes of macrophages: A potential strategy for natural products to treat inflammatory bone and joint diseases.
    Gao Y; Xu X; Zhang X
    Phytomedicine; 2023 Sep; 118():154952. PubMed ID: 37506402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization.
    Shi L; Gu H
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage-Targeted Therapeutics for Metabolic Disease.
    Peterson KR; Cottam MA; Kennedy AJ; Hasty AH
    Trends Pharmacol Sci; 2018 Jun; 39(6):536-546. PubMed ID: 29628274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage polarization in atherosclerosis.
    Yang S; Yuan HQ; Hao YM; Ren Z; Qu SL; Liu LS; Wei DH; Tang ZH; Zhang JF; Jiang ZS
    Clin Chim Acta; 2020 Feb; 501():142-146. PubMed ID: 31730809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent.
    Mohammadi A; Blesso CN; Barreto GE; Banach M; Majeed M; Sahebkar A
    J Nutr Biochem; 2019 Apr; 66():1-16. PubMed ID: 30660832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases.
    Tan HY; Wang N; Li S; Hong M; Wang X; Feng Y
    Oxid Med Cell Longev; 2016; 2016():2795090. PubMed ID: 27143992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage phenotypes in tissue repair and the foreign body response: Implications for biomaterial-based regenerative medicine strategies.
    Martin KE; García AJ
    Acta Biomater; 2021 Oct; 133():4-16. PubMed ID: 33775905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.